Inventor · disambiguated record
Philip Stewart Turnbull
Also filed as: TURNBULL PHILIP · TURNBULL PHILIP S · TURNBULL PHILIP STEWART
17 granted patents·10 pending applications·78 citations·filing 2002–2021
92Inventor score
Files withRECEPTOS LLC7SMITHKLINE BEECHAM CORP5GLAXOSMITHKLINE IP NO 2 LTD4GLAXOSMITHKLINE LLC3BLANC JEAN-BAPTISTE E1
Top patents by PatentIndex Score
27 records- 0191US7834063B2Benzonitryl and nitrobenzyl derivatives that modulate androgen receptorsGLAXOSMITHKLINE LLC·Filed 2005·Granted Nov 16, 2010·28 cites·17 claims
- 0290US8957104B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2013·Granted Feb 17, 2015·10 cites·12 claims
- 0387US7572820B2Chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2007·Granted Aug 11, 2009·11 cites·5 claims
- 0485US10196353B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Feb 5, 2019·3 cites·12 claims
- 0585US9533948B2Chemical compoundsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Jan 3, 2017·5 cites·6 claims
- 0683US10710963B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Jul 14, 2020·1 cites·4 claims
- 0783US8026262B2Chemical compoundsGLAXOSMITHKLINE LLC·Filed 2009·Granted Sep 27, 2011·7 cites·20 claims
- 0882US11040954B1CXCR3 receptor agonistsRECEPTOS LLC·Filed 2020·Granted Jun 22, 2021·2 cites·36 claims
- 0980US7514470B2Aniline derivatives as selective androgen receptor modulatorsSMITHKLINE BEECHAM CORP·Filed 2005·Granted Apr 7, 2009·4 cites·7 claims
- 1073US11299457B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Apr 12, 2022·0 cites·4 claims
- 1168US6943162B2Piperazinyltriazines as estrogen receptor modulatorsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Sep 13, 2005·6 cites·4 claims
- 1265US7649093B2Naphthalene compounds as selective estrogen receptor modulatorsGlaxo Smith Kline LLC·Filed 2005·Granted Jan 19, 2010·1 cites·17 claims
- 1362US7723385B2Aniline derivatives as selective androgen receptor modulatorsGLAXOSMITHKLINE LLC·Filed 2009·Granted May 25, 2010·0 cites·5 claims
- 1454US2024124394A1Carboxylic Acid Containing Indanyl Compounds for the Treatment of Neurodegenerative DiseasesCELGENE CORP·Filed 2021·Application pending·0 cites
- 1548US11066395B2Dimethylaminoethanol salt of a GLP-1 receptor modulatorRECEPTOS LLC·Filed 2017·Granted Jul 20, 2021·0 cites·16 claims
- 1647US2022194971A1Sphingosine 1 phosphate receptor modulatorsRECEPTOS LLC·Filed 2020·Application pending·0 cites
- 1747US2022194908A1Sphingosine 1 phosphate receptor modulatorsRECEPTOS LLC·Filed 2020·Application pending·0 cites
- 1846US8673948B2Chemical compoundsTURNBULL PHILIP STEWART·Filed 2011·Granted Mar 18, 2014·0 cites·15 claims
- 1945US2022227722A1Sphingosine 1 phosphate receptor modulatorRECEPTOS LLC·Filed 2020·Application pending·0 cites
- 2045US2022144788A1Sphingosine 1 phosphate receptor modulatorsRECEPTOS LLC·Filed 2020·Application pending·0 cites
- 2145US2006142387A1Chemical compoundsCADILLA RODOLFO·Filed 2004·Application pending·0 cites
- 2243US2006148893A1Chemical compoundsBLANC JEAN-BAPTISTE E·Filed 2004·Application pending·0 cites
- 2343US2009093464A1Naphthalene Derivatives as Modulators of the Glucocorticoid ReceptorSMITHKLINE BEECHMA CORP·Filed 2006·Application pending·0 cites
- 2442US2009170907A1Chemical CompoundsSMITHKLINE BEECHAM CORP·Filed 2006·Application pending·0 cites
- 2540US7189851B2Condensed heterocyclic compounds as calcitonin agonistsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Mar 13, 2007·0 cites·1 claims
- 2639US2019345133A1Cxcr3 receptor agonistsCELGENE INT II SARL·Filed 2017·Application pending·0 cites
- 2736US11530205B2GLP-1 receptor modulatorsRECEPTOS LLC·Filed 2018·Granted Dec 20, 2022·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →